Trial watch: Peptide-based vaccines in anticancer therapy

Trial watch: Peptide-based vaccines in anticancer therapy

Peptide-based anticancer vaccination aims at stimulating an immune response against one or multiple tumor-associated antigens (TAAs) following immunization with purified, recombinant or synthetically engineered epitopes. Despite high expectations, the peptide-based vaccines that have been explored i...

Full description

Bibliographic Details
Main Authors: Lucillia Bezu, Oliver Kepp, Giulia Cerrato, Jonathan Pol, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Format: Article
Language:English
Published: Taylor & Francis Group 2018-12-01
Series:OncoImmunology
Subjects:
car t cells
immune checkpoint blockers
magea3
mutational load
ny-eso-1
synthetic long peptides
tumor neoantigens
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1511506

Internet

http://dx.doi.org/10.1080/2162402X.2018.1511506

Similar Items